Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

被引:228
作者
Kanamaru, F
Youngnak, P
Hashiguchi, M
Nishioka, T
Takahashi, T
Sakaguchi, S
Ishikawa, I
Azuma, M
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Mol Immunol, Bunkyo Ku, Tokyo 1138549, Japan
[2] Tokyo Med & Dent Univ, Grad Sch, Dept Periodontal Dis, Bunkyo Ku, Tokyo 1138549, Japan
[3] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto, Japan
关键词
D O I
10.4049/jimmunol.172.12.7306
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The glucocorticoid-induced TNF receptor (GITR), which is a member of the TNF receptor family, is expressed preferentially at high levels on CD25(+)CD4(+) regulatory T cells and plays a key role in the peripheral tolerance that is mediated by these cells. GITR is also expressed on conventional CD4(+) and CD8(+) T cells, and its expression is enhanced rapidly after activation. In this report we show that the GITR provides a potent costimulatory signal to both CD25(+) and CD25(-) CD4(+) T cells. GITR-mediated stimulation induced by anti-GITR mAb DTA-1 or GITR ligand transfectants efficiently augmented the proliferation of both CD25(-)CD4(+) and CD25(+)CD4(+) T cells under the limited dose of anti-CD3 stimulation. The augmentation of T cell activation was further confirmed by the enhanced cell cycle progression; early induction of the activation Ags, CD69 and CD25; cytokine production, such as IL-2, IFN-gamma, IL-4, and IL-10; anti-CD3-induced redirected cytotoxicity; and intracellular signaling, assessed by translocation of NF-kappaB components. GITR costimulation showed a potent ability to produce high amounts of IL-10, which resulted in counter-regulation of the enhanced proliferative responses. Our results highlight evidence that GITR acts as a potent and unique costimulator for an early CD4(+) T cell activation.
引用
收藏
页码:7306 / 7314
页数:9
相关论文
共 47 条
[11]  
Ebata T, 2001, EUR J IMMUNOL, V31, P1410, DOI 10.1002/1521-4141(200105)31:5<1410::AID-IMMU1410>3.0.CO
[12]  
2-H
[13]   TUMOR-NECROSIS-FACTOR LIGAND SUPERFAMILY - INVOLVEMENT IN THE PATHOLOGY OF MALIGNANT-LYMPHOMAS [J].
GRUSS, HJ ;
DOWER, SK .
BLOOD, 1995, 85 (12) :3378-3404
[14]   Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR [J].
Gurney, AL ;
Marsters, SA ;
Huang, A ;
Pitti, RM ;
Mark, M ;
Baldwin, DT ;
Gray, AM ;
Dowd, P ;
Brush, J ;
Heldens, S ;
Schow, P ;
Goddard, AD ;
Wood, WI ;
Baker, KP ;
Godowski, PJ ;
Ashkenazi, A .
CURRENT BIOLOGY, 1999, 9 (04) :215-218
[15]  
Itoh M, 1999, J IMMUNOL, V162, P5317
[16]  
KIM YJ, 1993, J IMMUNOL, V151, P1255
[17]  
KOBATA T, 1994, J IMMUNOL, V153, P5422
[18]   MICE LACKING THE C-REL PROTOONCOGENE EXHIBIT DEFECTS IN LYMPHOCYTE-PROLIFERATION, HUMORAL IMMUNITY, AND INTERLEUKIN-2 EXPRESSION [J].
KONTGEN, F ;
GRUMONT, RJ ;
STRASSER, A ;
METCALF, D ;
LI, RL ;
TARLINTON, D ;
GERONDAKIS, S .
GENES & DEVELOPMENT, 1995, 9 (16) :1965-1977
[19]   Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation [J].
Kuniyasu, Y ;
Takahashi, T ;
Itoh, M ;
Shimizu, J ;
Toda, G ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (08) :1145-1155
[20]   Functions of newly identified members of the tumor necrosis factor receptor ligand superfamilies in lymphocytes [J].
Kwon, B ;
Youn, BS ;
Kwon, BS .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (03) :340-345